Ellison Institute of Technology, Oxford Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ellison Institute of Technology, Oxford Limited - overview
Established
2023
Location
Oxford, -, UK
Primary Industry
Biotechnology
About
Located in Oxford, the Ellison Institute of Technology focuses on delivering innovative solutions in health, food security, climate change, and artificial intelligence, driving advancements through research and collaboration on a global scale. Ellison Institute of Technology, founded in 2023 in Oxford, UK, is dedicated to developing innovative technological solutions across various domains. The institute was established to address urgent global challenges and does not operate as a subsidiary. Specific information regarding the founder is not available at this time.
The Ellison Institute of Technology (EIT) focuses on developing and deploying innovative solutions across four primary domains: health, food security, climate change, and artificial intelligence/robotics. EIT's core offerings include advanced preventive healthcare solutions that leverage technology for pathogen diagnostics and immune response modulation. In agriculture, the institute enhances crop resilience and yield through gene editing and sustainable practices, while its initiatives in carbon sequestration aim to mitigate rising atmospheric CO2 levels. EIT targets a diverse client base, including policymakers, industry leaders, and researchers globally, emphasizing collaboration across sectors to translate scientific discoveries into real-world applications.
EIT's solutions serve clients in North America, Europe, and parts of Asia, addressing pressing global challenges through research and innovation. EIT's revenue structure is primarily driven by partnerships, research collaborations, and educational programs. Through strategic collaborations with academic institutions and industry leaders, EIT engages in B2B transactions, providing customized solutions and technologies tailored to various sectors. These partnerships facilitate access to its research while fostering innovation in healthcare and sustainable agriculture.
Additionally, EIT offers education and scholarship programs that fully fund selected students' studies at the University of Oxford, generating revenue through program fees and partnerships. Financial transactions associated with these educational initiatives are typically structured around tuition funding and project-based grants, allowing for ongoing investment in research and development activities. Future growth for EIT includes the development of new products designed to enhance healthcare and agricultural technologies, with specific release dates to be announced. The institute plans to expand into emerging markets in Asia and Africa by 2025, targeting local industries and government partnerships to foster innovation.
Recent funding will be allocated to enhance research capabilities and support product development initiatives, ensuring that EIT remains at the forefront of addressing global challenges.
Primary Industry
Biotechnology
Sub Industries
Education/Training, Molecular Science, Genetics & Gene Therapy, Healthcare IT
Website
www.eit.org
Verticals
Artificial Intelligence, EdTech, HealthTech, Research (Non-Medical)
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.